Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Original Article
Author Details :
Volume : 2, Issue : 4, Year : 2016
Article Page : 309-311
Abstract
Aim: Comparison of topical Bromfenac versus topical Prednisolone acetate to control post cataract surgery ocular inflammation.
Materials and Methods: Effectiveness and safety of topical Bromfenac(0.09%) and topical Prednisolone acetate (1%) was evaluated in patients of cataract surgery in controlling inflammation. Two groups of patients each having 100 patients were enrolled in this study. Both the groups were comparable in baseline parameters. Patients in each group were followed for one month after cataract surgery. Visual acuity, post-operative inflammation was evaluated by detailed slit-lamp examination in both groups at first day, one week and one month after the surgery.
Results: The two groups had no statistically significant difference in post-operative inflammation and were well tolerated.
Conclusion: Bromfenac(0.09%) is an effective drug in controlling ocular inflammation after un-complicated cataract surgery having effect comparable to topical Prednisolone acetate(1%) with minimal side effects.
Keywords: Bromfenac, Cataract, Inflammation, Prednisolone
How to cite : Phogat J, Sachdeva S, Khanduja S, Rathi M, Bhatt N, To compare the effectiveness of prednisolone versus bromfenac in controlling the ocular inflammation after cataract surgery. Indian J Clin Exp Ophthalmol 2016;2(4):309-311
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.